Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis

NCT02912897 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: Cellular therapy with EBV specific autologous CTL infusion

Sponsor

Nantes University Hospital